Navigation Links
Endologix Reports 30% Third Quarter 2010 Revenue Growth
Date:10/27/2010

and administrative expenses in third quarter of 2010 included $575,000 in legal expense related to the patent disputes with Cook Medical and Bard Peripheral Vascular, Inc. and $290,000 in expenses related to the Nellix acquisition.  In total, the above amounts for litigation and business development expenses during the third quarter equaled $1.4 million, or $0.03 per share.

Total operating expenses for the nine months ended September 30, 2010 were $38.1 million, compared with $30.6 million for the nine months ended September 30, 2009.  Marketing and sales expenses increased to $23.1 million in the first nine months of 2010, up from $19.8 million in the same period last year.  Research, development and clinical expenses increased to $8.0 million in the first nine months of 2010, up from $4.5 million in the same period last year.  General and administrative expenses were $7.0 million, compared with $6.3 million for the nine months ended September 30, 2009.

Endologix reported a net loss for the third quarter of 2010 of $466,000 or $(0.01) per share, compared with a net loss of $156,000 or $(0.00) per share, for the third quarter of 2009.  For the nine months ended September 30, 2010, the Company reported a net loss of $1.1 million, or $(0.02) per share, compared with a net loss of $1.8 million, or $(0.04) per share, for the nine months ended September 30, 2009.  Total cash and cash equivalents were $22.9 million as of September 30, 2010, compared with total cash and cash equivalents of $24.1 million as of December 31, 2009.

"Excluding legal expenses related to the Cook and Bard patent cases and the business development investments noted above, our core business was profitable during the third quarter.  This was driven by strong revenue growth and improving gross margins," stated Endologix Chief Financial Officer Bob Krist.  "During the quarter we added 3 new sales representatives, bringing the total number o
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that surveyed ... a greater effect on quality of life is ... the high level of subjectivity and variability of ... thought leaders state that it is difficult to ...
(Date:5/19/2013)... 2013 Claret Medical, Inc. announced the publication of ... et al., Histopathology of Embolic Debris Captured ... in Circulation, May 7 th this research is the ... Rotterdam, the Netherlands and the pathology team of ... Pathology Institute, Gaithersburg, Maryland.  This is the ...
(Date:5/19/2013)... Fla. , May 19, 2013  The ... and low temperature radiofrequency (RF) energy is effective ... eliminates or reduces the need for medication 10 ... assessment presented today at the Digestive Disease Week ... Orlando, Florida . "The ...
Breaking Medicine Technology:For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3
... Increases in deaths from opioid drugs such as OxyContin may ... the news, according to a study from Children,s Hospital Boston and ... patterns of opioid deaths and patterns of news coverage between 1999 ... It found that spikes in media coverage often preceded an increase ...
... , , KIBBUTZ SHAMIR, Israel, Nov. 18 Shamir ... a leading provider of innovative products and technology to the ... third quarter ended September 30, 2009. , For the quarter ... $36.1 million for the third quarter of 2008. Gross ...
Cached Medicine Technology:Breaking the News, or Fueling the Epidemic? News Coverage of Opioid-Related Deaths Often Precede an Increase in Deaths, Study Finds 2Breaking the News, or Fueling the Epidemic? News Coverage of Opioid-Related Deaths Often Precede an Increase in Deaths, Study Finds 3Breaking the News, or Fueling the Epidemic? News Coverage of Opioid-Related Deaths Often Precede an Increase in Deaths, Study Finds 4Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 2Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 3Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 4Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 5Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 6Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 7Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 8Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 9Shamir Optical Industry Ltd. Reports Third Quarter 2009 Results 10
(Date:5/21/2013)... 21, 2013 Dr. James C. Wittig, ... of the Sarcoma Division of the John Theurer Cancer ... has been named one of the top 13 Orthopedic ... Dr. Wittig is one of approximately 125 surgeons ... was created by surveying thought leaders in the field ...
(Date:5/21/2013)... Brunswick Laboratories, Inc. announces that AOAC ... standardization of validated analytical methods, has approved the ... the USDA, as a First Action Official MethodSM ... after extensive review by an AOAC expert review ... U.S. Department of Agriculture. , Jin Ji, PhD., ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... 2013 USA Book News announced Monday ... Peak Performance" won the top honor in its 2013 ... over a multitude of international titles published from 2011-2013, ... acclaim from both mainstream and new age audiences looking ... and spiritually. , “The Infinity Zone” is ...
(Date:5/20/2013)... Southfield, Michigan (PRWEB) May 21, 2013 This ... National Dog Bite Prevention Week (May 19th-May 25th) is an ... dog bite attacks and by encouraging dog owners to properly ... a dog. , Michigan dog bite lawyers at ... animal attacks in cases throughout Michigan. The personal injury law ...
Breaking Medicine News(10 mins):Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2
... Hospital is the only pediatric hospital in the ... The American Nurses,Credentialing Center (ANCC) has awarded DMC ... nursing. Recognized as one of the,highest distinctions a ... five,percent of all U.S. hospitals have achieved this ...
... April 17 The Connecticut,Hospice, Inc., the nation,s ... from its first class of The Norma F. ... by a,generous grant merited by the Connecticut Hospice,s ... for education and,training in hospice and palliative care. ...
... explain antidepressants, effectiveness , , THURSDAY, April 17 (HealthDay News) ... old brain cells to their more plastic youthful condition ... only provides a possible new explanation for the antidepressant ... prospect that it could be used to treat other ...
... drinkers and heavy,smokers develop Alzheimer,s disease years earlier ... smoke heavily, according to research that,will be presented ... Meeting in Chicago, April 12-19, 2008., "These ... we can,reduce or eliminate heavy smoking and drinking, ...
... N.Y., April 17 CTG (Nasdaq: CTGX ),an ... that it would release its 2008 first quarter,financial results ... company,will hold a conference call to discuss its financial ... 10:00 a.m. Eastern Time. CTG,Chairman and Chief Executive Officer ...
... Calif., April 17 The National Center for,Autism ... for autism research, education and family support,services has ... are,flocking to NCARE resulting from the announcement to ... that families desperately need centralized,autism resources., Soonhee ...
Cached Medicine News:Health News:Children's Hospital of Michigan Awarded Prestigious Magnet Status 2Health News:The Norma F. Pfriem International Fellowship in Hospice and Palliative Care Nursing 2Health News:Prozac Makes Old Brain Cells Young 2Health News:Prozac Makes Old Brain Cells Young 3Health News:Alzheimer's Starts Earlier for Heavy Drinkers, Smokers 2Health News:CTG Announces 2008 First Quarter Conference Call and Webcast Information 2Health News:California's First Non-profit Center for Autism Research, Education and Family Services 2
... Visionblue is a staining solution for ... required for performing a safe phaco-emulsification ... lens capsule may result in an ... risk of radial capsule tears and ...
Rhex-ID (Trypan Blue 0.8 mg)....
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Auto refractometer....
Medicine Products: